Advertisement

People with HIV Have a 10-Fold Higher Risk for Invasive Meningococcal Disease — Physician’s First Watch

Medical News |
October 29, 2013

People with HIV Have a 10-Fold Higher Risk for Invasive Meningococcal Disease

By Joe Elia

Being seropositive for HIV in New York City puts a person at a roughly 10-fold greater risk for invasive meningococcal disease, a study in the Annals of Internal Medicine finds.

Researchers examined city registry data from 2000 to 2011. The incidence rates of invasive meningococcal disease were 0.34 per 100,000 overall and 3.4 per 100,000 among those with HIV. Among seropositives, those with CD4+ counts under 200 were five times more likely to have invasive meningococcal disease than those with higher counts.

The CDC does not include HIV-seropositive adults as a risk group warranting meningococcal vaccination; the authors recommend that the agency revise its position.

Paul Sax, an ID specialist forNEJM Journal Watch, commented: "These data certainly suggest that people with HIV are at increased risk for this potentially life-threatening complication, and raise the question of whether meningococcal immunization should be considered standard-of-care for HIV-infected adults as well as adolescents."

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement